Congratulations to Dr. Nikolai Podolsev
@yale-hematology.bsky.social, whose leadership of a #clinicaltrial at Smilow Cancer Hospital resulted in FDA approval of #Besremi ( #ropeginterferon ) for treatment of #essentialthrombocythemia (ET).
thelancet.com/journals/lan...